Title of article :
Preparation, distribution, stability and tumor imaging properties of [62Zn] bleomycin complex in normal and tumor-bearing mice
Author/Authors :
Jalilian, A.R Atomic Energy Organization of Iran , Fateh, B Atomic Energy Organization of Iran , Ghergherehchi, M Islamic Azad University of Iran - Tehran , Karimian, A Atomic Energy Organization of Iran , Matlloobi, M Atomic Energy Organization of Iran
Abstract :
Backgrounds: Bleomycin (BLM) has been labeled with radioisotopes and widely used in therapy and diagnosis. In this study BLM was labeled with [62Zn] zinc chloride for oncologic PET studies.
Materials and methods: The complex was obtained at the pH=2 in normal saline at 90 ° C in 60 min. Radio-TLC showed an overall radiochemical yield of 95-97% (radiochemical purity > 97%). Stability of complex was checked in vitro in mice and human plasma/urine.
Results: Preliminary in vivo studies performed to determine complex stability and distribution of [62Zn] BLM in normal and fibrosarcoma-bearing mice. [62Zn] BLM accumulated significantly in induced fibrosarcoma tumors in mice according to bio-distribution/imaging studies.
Conclusion: [62Zn] BLM can be used in PET oncology studies due to its suitable physico-chemical properties as a diagnostic complex in vitro and in vivo. Further studies should be performed for evaluation of the complex behavior in higher animals. Iran . J. Radiat. Res., 2003 1(1): 37 - 44.
Keywords :
PET , pharmacokinetic , biodistribution , zinc-62 , bleomycin
Journal title :
Astroparticle Physics